Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT01005784
NCT01005784CompletedPhase 4

Fixed Versus Flexible GnRH Antagonist Initiation

Aristotle University Of Thessaloniki1 site in 1 country146 target enrollmentStarted: June 2005Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
146
Locations
1
Primary Endpoint
Luteinizing hormone rise
Study OverviewStudy DesignEligibility CriteriaArms & InterventionsOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

This is a comparison of pregnancy achievement between two GnRH antagonist protocols which differ in the timing of GnRH antagonist initiation.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 39 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •< 39 years of age
  • •BMI 18.5-29.9
  • •<= 3 previous IVF cycles

Exclusion Criteria

  • •Endometriosis

Arms & Interventions

fixed

Active Comparator

Intervention: Cetrorelix (Cetrotide) (Drug)

flexible

Experimental

Intervention: Cetrorelix (Cetrotide) (Drug)

Outcomes

Primary Outcomes

Luteinizing hormone rise

Time Frame: 3-14 days (duration of ovarian stimulation)

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Evaluation of fixed versus flexible GnRH antagonist protocols outcomes in controlled ovarian stimulation in polycystic ovary syndrome.POLY CYSTIC OVARIAN SYNDROME.Sclerocystic ovary syndrome Stein-Leventhal syndrome
IRCT201101135181N5Tehran University of Medical SciencesVice-chancellor of research,100
Completed
Phase 4
Flexible GnRH Antagonist vs Flare up GnRH Agonist Protocol in Poor RespondersInfertilityPremature Ovarian Failure
NCT00417066Eugonia270
Completed
Not Applicable
Pregnancy Outcomes With a GnRH Antagonist Protocol Versus GnRH-Agonist Protocol in ICSI CyclesInfertility
NCT00485537Clinic and Research Center in Human Reproduction Roger Abdelmassih2,005
Completed
Not Applicable
The use of a flexible (GnRH) antagonist versus minidose long GnRH agonist for ovarian stimulation in poor-responder patients undergoing the (IVF) program
ISRCTN84867406Al-Amal Maternity Hospital (Jordan)124
Unknown
Not Applicable
Luteal Antagonist Versus Conventional Treatment in Women With Severe Early Ovarian Hyperstimulation Syndrome (OHSS)Ovarian Hyperstimulation Syndrome
NCT02392520Eugonia40